Estriol 0.5%/Testosterone 0.5% Vaginal Gel is a specially compounded medication, designed as a gel-like semisolid formulation for easy and controlled application in the vaginal area. It is used to treat conditions such as Vulvovaginal Atrophy, Hypoestrogenism, Dyspareunia, Genitourinary Syndrome of Menopause, and Lichen Sclerosus. This topical gel is applied directly to the affected area, delivering medication while providing lubrication and therapeutic effects for various gynecological purposes.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Estriol 0.5%/Testosterone 0.5% Vaginal Gel is a specially compounded medication designed to address various conditions associated with menopause and vulvovaginal atrophy. This includes atrophic vaginitis, vulvovaginal atrophy, dyspareunia, genitourinary syndrome of menopause, and lichen sclerosus. The gel is a unique blend of Estriol, a form of estrogen that aids in reducing inflammation and enhancing the health of the vaginal tissue, and Testosterone, which is known to boost libido and sexual function.
This medication is a gel-like semisolid formulation dispensed in a tube, specifically created for easy and controlled application in the vaginal area. It delivers the medication directly to the affected area, providing both lubrication and therapeutic effects. The medication is absorbed through the skin, allowing for targeted treatment of the conditions it is designed to address.
It is crucial to note that this medication should not be used by women who are pregnant or breastfeeding. Additionally, it is important to discuss any other medications or supplements that you may be taking with your healthcare provider before starting this medication. This is to ensure there are no potential interactions or contraindications.
It works by reducing inflammation, improving the health of the vaginal tissue, and enhancing libido and sexual function. As with any medication, it is essential to follow the instructions provided by your healthcare provider to ensure the best possible outcome.
If you have any questions or concerns about Estriol 0.5%/Testosterone 0.5% Vaginal Gel or any other compounded medications, please do not hesitate to reach out. We are a team of experienced compounding pharmacists who are here to assist you with your healthcare needs.
Estriol 0.5%/Testosterone 0.5% Vaginal Gel is a compounded formulation specifically designed for the treatment of various gynecological conditions such as Atrophic Vaginitis, Vulvovaginal Atrophy, Dyspareunia, Genitourinary Syndrome of Menopause, and Lichen Sclerosus. This unique combination of Estriol, a weak estrogen, and Testosterone, a hormone known to improve libido and sexual function, works synergistically to alleviate symptoms associated with these conditions.
Estriol aids in reducing inflammation and enhancing the integrity of the vaginal mucosa, thereby providing relief from symptoms such as vaginal dryness, itching, and burning. Testosterone, on the other hand, contributes to improved sexual function and libido. Together, these active ingredients not only provide symptomatic relief but also help reduce the risk of recurrent urinary tract infections, a common complication associated with these conditions.
The gel is designed for intravaginal application, ensuring targeted delivery of the medication. It should be applied once daily for a period of up to 12 weeks. During this treatment period, patients should be closely monitored for any signs of estrogen-related adverse effects such as breast tenderness, nausea, and headache, as well as testosterone-related adverse effects like acne, hirsutism, and deepening of the voice. In case of any such adverse effects, it is recommended to adjust the dose or discontinue the medication as necessary.
If you have any queries or concerns regarding the use of Estriol 0.5%/Testosterone 0.5% Vaginal Gel for the treatment of Atrophic Vaginitis, Vulvovaginal Atrophy, Dyspareunia, Genitourinary Syndrome of Menopause, or Lichen Sclerosus, please do not hesitate to reach out for further information.
Estriol 0.5%/Testosterone 0.5% Vaginal Gel is a specially compounded medication designed to address various conditions associated with menopause and vulvovaginal atrophy. This unique formulation combines Estriol, a type of estrogen, and Testosterone, an androgen, to effectively alleviate symptoms of atrophic vaginitis, vulvovaginal atrophy, dyspareunia, genitourinary syndrome of menopause, and lichen sclerosus.
The gel is designed for direct application to the affected area, where it is absorbed through the skin. It functions by reducing inflammation, enhancing lubrication, and restoring the body's natural hormonal balance. This combination of effects can significantly alleviate symptoms such as dryness, itching, burning, and pain that are commonly associated with these conditions.
When using Estriol 0.5%/Testosterone 0.5% Vaginal Gel, it is crucial to adhere to the instructions provided by your healthcare provider. The gel is typically applied once or twice daily, depending on the severity of the condition. It is essential to use the medication as directed and not to exceed the recommended dosage to ensure its effectiveness and safety.
It can significantly reduce symptoms and improve the quality of life for those suffering from these conditions. If you have any questions or concerns about using this medication, it is recommended to consult with your healthcare provider.
This compounded formulation of Estriol 0.5%/Testosterone 0.5% Vaginal Gel is a specialized medication designed for targeted application in the vaginal area. It is primarily used in the treatment of various gynecological conditions such as Vulvovaginal Atrophy, Hypoestrogenism, Dyspareunia, Genitourinary Syndrome of Menopause, and Lichen Sclerosus. This formulation may also be beneficial in addressing symptoms such as vaginal dryness, itching, burning, and irritation, which are often associated with these conditions.
Furthermore, this gel formulation can potentially enhance sexual satisfaction by reducing discomfort during intercourse. It is crucial to understand that this medication should only be used for the conditions mentioned above, unless otherwise directed by a healthcare provider. Using this formulation for other conditions without professional medical advice may lead to unwanted side effects or ineffective treatment.
Patients using this formulation should be aware of potential side effects, which may include vaginal burning, itching, or irritation. If any of these side effects occur, it is recommended to immediately contact a healthcare provider for advice. This formulation is designed to provide therapeutic effects while ensuring easy and controlled application, but any concerns or questions regarding its use should be directed to a healthcare professional.
This is a gel-like semisolid formulation that is dispensed in a tube. It is specifically created for easy and controlled application in the vaginal area. It delivers medication and provides lubrication and therapeutic effects for various gynecological purposes.
The gel is designed to deliver medication to the vaginal area for various gynecological purposes. It also provides lubrication and therapeutic effects.
The gel is dispensed from a tube for easy and controlled application. It is meant to be applied directly to the vaginal area.
The active ingredients in the gel are Estriol and Testosterone, each at a concentration of 0.5%.
The gel delivers medication directly to the vaginal area, which can be beneficial for treating various gynecological conditions. It also provides lubrication and therapeutic effects.
As with any medication, there may be potential side effects. It is recommended to consult with your healthcare provider for detailed information.
This medication is typically prescribed by a healthcare provider and is intended for specific gynecological purposes. It is not recommended for use without professional medical advice.
The frequency of use will depend on the specific medical condition and the advice of your healthcare provider. Always follow the instructions provided by your healthcare provider or pharmacist.
It is important to consult with your healthcare provider before using any medication while pregnant or breastfeeding. They will be able to provide advice based on your specific situation and the potential risks and benefits.
If you experience any adverse reactions while using the gel, stop using it immediately and contact your healthcare provider.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert/apply intravaginally